Background-Genetic determinants of blood pressure (BP) response to potassium, or potassium sensitivity, are largely unknown. We conducted a genome-wide linkage scan and positional candidate gene analysis to identify genetic determinants of potassium sensitivity. Methods and Results-A total of 1906 Han Chinese participants took part in a 7-day high-sodium diet followed by a 7-day high-sodium plus potassium dietary intervention. BP measurements were obtained at baseline and after each intervention using a random-zero sphygmomanometer. Significant linkage signals (logarithm of odds [LOD] score, Ͼ3) for BP responses to potassium were detected at chromosomal regions 3q24-q26.1, 3q28, and 11q22.3-q24.3. Maximum multipoint LOD scores of 3.09 at 3q25.2 and 3.41 at 11q23.3 were observed for absolute diastolic BP (DBP) and mean arterial pressure (MAP) responses, respectively. Linkage peaks of 3.56 at 3q25.1 and 3.01 at 11q23.3 for percent DBP response and 3.22 at 3q25.2, 3.01 at 3q28, and 4.48 at 11q23.3 for percent MAP response also were identified. Angiotensin II receptor, type 1 (AGTR1), single-nucleotide polymorphism rs16860760 in the 3q24-q26.1 region was significantly associated with absolute and percent systolic BP responses to potassium (Pϭ0.0008 and Pϭ0.0006, respectively). Absolute (95% CI) systolic BP responses for genotypes C/C, C/T, and T/T were Ϫ3.71 (Ϫ4.02 to Ϫ3.40), Ϫ2.62 (Ϫ3.38 to Ϫ1.85), and 1.03 (Ϫ3.73 to 5.79) mm Hg, respectively, and percent responses (95% CI) were Ϫ3.07 (Ϫ3.33 to Ϫ2.80), Ϫ2.07 (Ϫ2.74 to Ϫ1.41), and 0.90 (Ϫ3.20 to 4.99), respectively. Similar trends were observed for DBP and MAP responses. Conclusions-Genetic regions on chromosomes 3 and 11 may harbor important susceptibility loci for potassium sensitivity. Furthermore, the AGTR1 gene was a significant predictor of BP responses to potassium intake. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00721721. (Circ Cardiovasc Genet. 2010;3:539-547.)
R andomized clinical trials have documented that potassium supplementation reduces blood pressure (BP) among hypertensive and normotensive participants. [1] [2] [3] These clinical trials also have shown that BP response to potassium intake varies substantially among individuals. 1, 4 Furthermore, previous data from the Genetic Epidemiology Network of Salt Sensitivity (GenSalt) study indicated that BP response to potassium intake, known as potassium sensitivity, has a genetic component, with moderate heritability estimates for this phenotype. 5 Still, few studies have been conducted to examine the genetic etiology of potassium sensitivity. [5] [6] [7] Knowledge of the genetic mechanisms underlying BP response to potassium not only will provide a novel strategy for the primary and secondary prevention of hypertension, but also may provide further insights into the complex and multifaceted biological mechanisms underlying hypertension susceptibility.
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The objective of the current study was to identify chromosomal regions harboring quantitative trait loci (QTLs) for systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) responses to potassium intake by conducting a genome-wide linkage scan. In addition, linkage results were followed-up by genotyping single-nucleotide polymorphisms (SNPs) located in positional candidate genes and conducting association analyses to examine their relationship with BP responses to potassium intake.
Methods

Study Population
The GenSalt study was conducted in a Han Chinese population with habitually high-sodium intake in rural areas of northern China. A community-based BP screening was conducted among persons aged 18 to 60 years in the study villages to identify potential probands and their families. Those with a mean SBP between 130 and 160 mm Hg, a DBP between 85 and 100 mm Hg, and no use of antihypertensive medications, as well as their parents, spouses, siblings, and offspring were recruited as volunteers for the study. Detailed eligibility criteria for the probands and parents, siblings, spouses, and offspring have been presented elsewhere. 8 Individuals who had stage 2 hypertension, secondary hypertension, clinical cardiovascular disease, chronic kidney disease, or diabetes; used antihypertensive medications; or were pregnant, heavy alcohol drinkers, or currently on a low-sodium diet were excluded from the study. Only probands, siblings, spouses, and offspring were eligible for the dietary intervention. Of the 1906 eligible participants, 1843 (96.7%) completed the potassium intervention.
Institutional review boards at all of the participating institutions approved the GenSalt study. Written informed consents for the baseline observation and for the intervention program were obtained from each participant.
Potassium Supplementation Intervention
The study participants were given a high-sodium diet (307.8 mmol of sodium per day) for 7 days. After that, they received a 60-mmol potassium supplementation while continuing on the high-sodium diet for another 7 days. One 20-mmol potassium pill (Klor-Con M20 potassium tablets; Upsher-Smith Laboratories, Maple Grove, Minn) was given during breakfast, lunch, and dinner. Total energy intake was varied according to each participant's baseline energy intake. All study foods were cooked without salt, and prepackaged salt was added to the individual study participant's meal when it was served by the study staff. To ensure compliance with the intervention program, participants were required to have their breakfast, lunch, and dinner at the study kitchen under supervision of the study staff during the entire study period. The study participants were instructed to avoid consuming any foods that were not provided by study personnel. Three timed urinary specimens (1 24-hour and 2 overnight) were collected at baseline and at the end of each phase of intervention (days 5, 6, and 7) to monitor compliance to the dietary sodium and potassium interventions among all participants. In addition, a random subsample of 238 participants collected the 24-hour specimens at baseline and each intervention phase using 2 separate containers (1 for the overnight and 1 for the daytime). Regression equations of 8-hour overnight excretions on 24-hour excretions of sodium and potassium were calculated using data from the subsample for each intervention phase separately. These formulas were used to calculate the 24-hour urinary excretions of sodium and potassium based on 8-hour overnight values in all study participants. The mean of 3 24-hour measures (1 collected 24-hour measure and 2 estimated 24-hour measures) were used to estimate each participant's average 24-hour urinary excretion for each intervention phase. The results from the 24-hour urinary excretions of sodium and potassium showed excellent compliance with the study diet: the meanϮSD 24-hour urinary excretions of sodium and potassium were 242.4Ϯ66.7 and 36.9Ϯ9.6 mmol at baseline, 244.3Ϯ37.7 and 35.7Ϯ7.5 mmol during the high-sodium intervention, and 251.9Ϯ36.9 and 77.3Ϯ12.6 mmol during the potassium intervention.
Phenotype Measurement
A standard questionnaire was administered by trained staff at the baseline examination to collect information on family structure, demographic characteristics, personal and family medical history, and lifestyle risk factors. Three morning BP measurements were obtained according to a standard protocol during each of the 3 days of baseline observation and on days 5, 6, and 7 of each intervention period. All BP readings were measured by trained and certified observers using a random-zero sphygmomanometer. 9 BP was measured with the participant in the sitting position after 5 minutes of rest. In addition, participants were advised to avoid alcohol, cigarette smoking, coffee and tea, and exercise for at least 30 minutes before their BP measurements. All BP observers were blinded to the participant's dietary intervention. Body weight and height were measured twice in light indoor clothing without shoes during the baseline examination. Body mass index was calculated as weight in kilograms per height in meters squared.
Absolute BP response to potassium was calculated as the mean of 9 measurements on days 5, 6, and 7 during the potassium intervention minus the mean of 9 measurements during the high-sodium intervention, and percent response to potassium was calculated as the absolute response divided by the mean of 9 measurements on days 5, 6, and 7 during the high-sodium intervention multiplied by 100. The pairwise correlations of all phenotypes are shown in online-only Data Supplement Table 1 .
Microsatellite Marker Genotyping
Lymphocytic DNA samples were obtained from GenSalt family members (probands, parents, spouses, siblings, and offspring) and used for genotyping microsatellite markers spaced at approximately 9-cM intervals (359 markers, Marshfield Screening Set 12). Microsatellite genotyping used fluorescently labeled polymerase chain reaction primers for marker amplification followed by capillary electrophoresis on automated DNA sequencers (ABI 3730 DNA Analyzer; Applied Biosystems; Carlsbad, Calif). Quality control samples included blind duplicates, no DNA controls, and CEPH DNA standards. Genotypes were assigned using GeneMapper software (Applied Biosystems). Affected-Sib-Pair Interval Mapping and Exclusion 10 and Graphical Representation of Relationships 11 software packages were used to check for potential misreported relationships in the GenSalt family pedigrees. PedCheck 12 and MapMaker/Sibs 13 were used to check for Mendelian inconsistencies within families for each marker.
Candidate Gene and SNP Selection and Genotyping
A positional candidate gene approach was used to select genes SNPs for the association analysis. A total of 912 candidate genes previously reported to be associated with BP-related disorders were identified using the Human Genome Epidemiology Navigator and the following search terms: hypertension; hypertension, malignant; hypertension, portal; hypertension, pregnancy-induced; hypertension, pulmonary; hypertension, renal; hypertension, renovascular; and hypotension. 14 Of these 912 genes, 11 positional candidate genes were selected for examination because they were located in chromosomal regions exhibiting logarithm of odds (LOD) scores of Ն3 in our linkage analysis. A total of 133 functional and tag SNPs providing Ͼ75% coverage of common polymorphisms in positional candidate genes and their flanking regions (5000 bp) were genotyped using oligonucleotide ligation-based SNPlex assays (Chinese National Human Genome Center; Beijing, China) and chip-based hybridization assays (Affymetrix Inc; Santa Clara, Calif). 15 Data quality control revealed 20 SNPs with a minor allele frequency Ͻ0.01, 1 SNP with a low genotyping call rate (Ͻ85%), and 1 SNP that significantly deviated from Hardy-Weinberg equilibrium (P value adjusted for correlated tests [P ACT ] Ͻ0.05). After exclusion of these 22 SNPs, a total of 111 SNPs remained (see online-only Data Supplement Table 2 ).
Statistical Analysis
The mean or percent of each baseline characteristic and BP response variable was calculated for each study participant. Allele frequencies from the entire GenSalt sample were used to calculate the multipoint identity by descent estimates with Merlin software. 16 Multipoint quantitative trait linkage analysis was conducted using SOLAR software 17 and adjusted absolute and percent BP response phenotypes. Phenotypes were adjusted for age and room temperature during BP measurement separately within sex and field center groups. Bivariate linkage analyses also were conducted to determine whether similarly adjusted baseline BP phenotypes and the BP response phenotypes had shared genetic factors.
Additive associations between single SNPs and absolute and percent BP responses to potassium intervention were assessed using a mixed linear regression model. A sandwich estimator was used to account for the nonindependence of family members. This method assumes the same degree of dependency among family members. Age, sex, BP measurement, room temperature, and study site were adjusted in multivariable analyses. To adjust for multiple comparisons, an adjusted P value using the P ACT method was calculated for each SNP. 18 For SNPs with an adjusted PϽ0.05, we estimated the mean effect size and 95% CI for each genotype using a mixed linear regression model. To assess whether significant BP response findings were independent of baseline BP levels, we added the appropriate baseline BP measure as a covariate in sensitivity analyses. These analyses were conducted using SAS version 9.1 (SAS Institute; Cary, NC) and R version 2.8.1 (www.r-project.org) statistical software. Finally, to determine whether significant SNPs explained some of the observed linkage in its corresponding chromosomal region, linkage analyses with phenotype adjustment for the original covariates plus any significant SNP findings were conducted.
Results
The baseline characteristics of 3142 participants, including 676 probands, 69 spouses, 1236 parents, 956 siblings, and 205 offspring from 633 families are presented in Table 1 . Average baseline SBP ranged from 107 mm Hg among offspring to 137 mm Hg among parents; DBP from 65 mm Hg among offspring to 80 mm Hg among probands; and MAP from 79 mm Hg among offspring to 96 mm Hg among probands. Among the 1843 participating probands, spouses, siblings, and offspring, average SBP, DBP, and MAP decreased during the potassium intervention. For example, absolute SBP, DBP, and Data are presented as meanϮSD, unless otherwise indicated. A total of 1236 parents did not take part in the dietary intervention and only have baseline data available.
Of the 1906 probands, spouses, siblings, and offspring with baseline data, 1843 (96.7%) completed the dietary intervention. BMI indicates body mass index; NA, Not applicable.
MAP responses were Ϫ4.4, Ϫ1.6, and Ϫ2.5 mm Hg, respectively, among study probands. All BP response phenotypes were normally distributed.
Genome-wide linkage results for absolute and percent BP responses to potassium are illustrated in Figure 1A and 1B, respectively. We observed linkage (LOD score, Ͼ3) of BP responses to chromosomal regions 3q24-q26.1, 3q28, and 11q22.3-q24.3. Maximum multipoint LOD scores of 3.09 at 3q25.2 and 3.41 at 11q23.3 were observed for absolute DBP and MAP responses to potassium, respectively ( Table 2 ). Linkage peaks of 3.56 at 3q25.1 and 3.01 at 11q23.3 for percent DBP response and 3.22 at 3q25.2, 3.01 at 3q28, and 4.48 at 11q23.3 for MAP response also were identified ( Table 2 ). Bivariate linkage analyses yielded 1 significant finding in the 11q22.4-q24.3 region for baseline MAP and percent MAP responses to potassium, with a maximum multipoint LOD score of 3.88.
Chromosomal region 3q24-q26.1 harbored 2 candidate genes (angiotensin II receptor, type 1 [AGTR1] and purinergic receptor P2 years, G-protein coupled, 12 [P2RY12]), which have been previously implicated in BP-related disorders (Figure 2A ). Sim- KCNJ1] ), which also have been associated with BP-related phenotypes in past studies ( Figure 2B) . Figure 3 shows the association between 111 SNPs in the 11 positional candidate genes and absolute ( Figure 3A) and percent ( Figure 3B ) SBP, DBP, and MAP responses to the potassium intervention. Only AGTR1 SNP rs16860760 (minor allele frequency, 7%) was significantly associated with any of the BP responses. Absolute and percent BP responses to the potassium intervention, by rs16860760 genotypes, are shown in Figure 4A Ϫ1.96), Ϫ1.47 (Ϫ2.07 to Ϫ0.88), and 1.45 (Ϫ2.13 to 5.03) mm Hg, respectively (raw and adjusted P values for linear trend, 0.003 and 0.18, respectively), and percent responses of Ϫ2.37 (Ϫ2.66 to Ϫ2.08), Ϫ1.50 (Ϫ2.21 to Ϫ0.80), and 1.86 (Ϫ2.25 to 5.96), respectively (raw and adjusted P values for linear trend, 0.004 and 0.19, respectively), for genotypes C/C, C/T, and T/T. Inclusion of the appropriate baseline BP measure as an additional covariate in sensitivity analyses for each BP response phenotype did not change these findings. Multipoint linkage analysis of chromosome 3, with an additional phenotype adjustment for rs16860760, explained some of the linkage observed at both 3q24-q26.1 and 3q28. In this analysis, only 1 phenotype (percent DBP response to potassium intake) achieved a significant maximum multipoint LOD score of 3.27 at 3q25.1.
Discussion
To our knowledge, the current study is the first to identify chromosomal regions harboring potentially important QTLs for potassium sensitivity. Maximum multipoint LOD scores of 3.56 at 3q25.1, 3.01 at 3q28, and 4.48 at 11q23.3 were observed for the BP response phenotypes. Furthermore, analysis of positional candidate genes revealed the AGTR1 gene as a potentially important genetic determinant of potassium sensitivity. We identified a significant and inverse dose-allele relationship between the minor T allele of AGTR1 marker rs16860760 and SBP response to potassium intake, with similar trends observed for DBP and MAP responses. In aggregate, these findings have important implications for future genetics research. The chromosomal regions localized in this study provide clues for further investigations aimed at identifying novel genes involved in potassium sensitivity. In addition, we provide early evidence of a definitive genetic mechanism underlying this complex phenotype.
Although many important genetic studies of BP have been conducted, 19, 20 the GenSalt study is, to our knowledge, the first and only study to examine the genetic etiology of BP responses to dietary potassium intake. Because microsatellite markers were genotyped for all family members (including parents) and multipoint methods were used in the analysis, the current study had increased power to detect linkage signals. The power to detect linkage and association was further enhanced by the large number of BP measures that were collected for each participant, which should have reduced measurement error. Study attributes, including the recruitment of all Han Chinese participants, should make the association analysis robust to population stratification. The study participants were also similar with respect to lifestyle risk factors, including diet and physical activity, which minimized the confounding effects of environment on genotype-phenotype associations. The majority (96.8%) of participants completed the dietary intervention, and compliance with the study interventions, as assessed by urinary excretion of sodium and potassium during each intervention period, was excellent. Finally, stringent quality control procedures were used during measurement of BP and the other study covariates, conduct of the dietary interventions, genotyping, and marker data cleaning. Individuals with clinical cardiovascular disease, chronic kidney disease, and diabetes were excluded from the current study; therefore, our findings might not be directly generalizable to these patients.
We detected significant linkage signals for DBP and MAP responses to potassium intake at 3q24-q26.1 and 3q28. Although this linkage analysis is the first for potassium sensitivity, past linkage scans have implicated this region in relation with other BP-related phenotypes. [21] [22] [23] [24] [25] For example, Rice and colleagues 24 found evidence of linkage to baseline BP values on 3q28 in the Health, Risk Factors, Exercise Training and Genetics Family Study. Furthermore, in a genome-wide linkage scan of Finnish siblings by Perola and colleagues, 22 the strongest evidence for linkage to hypertension was found for an intragenic AC-repeat microsatellite marker in the AGTR1 gene located in the 3q21-q25 region. In aggregate, these data provide strong evidence that important QTLs for potassium sensitivity may exist on the long arm of chromosome 3. However, replication studies examining a similar phenotype are needed.
Follow-up analysis of positional candidate genes in the 3q24-q26.1 region of chromosome 3 identified the AGTR1 gene as a potentially important genetic determinant of potassium sensitivity. AGTR1 encodes the angiotensin II, type 1, receptor, a critical component of the renin-angiotensin-aldosterone system. 26 Agonism of this receptor by angiotensin II increases aldosterone, which acts on renal distal tubules to increase the resorption of sodium and water and the excretion of potassium, subsequently increasing BP. 27, 28 Polymorphisms in this gene could therefore affect physiological responses to potassium intake. Thus, the AGTR1 gene is not only a statistically significant, but also a biologically plausible candidate for potassium sensitivity. Although the AGTR1 gene has not been studied previously in relation to potassium sensitivity, it has been associated with other BP phenotypes. 29 -31 Findings of Bonnardeaux and colleagues 29 and Zhu and colleagues 30 showed significant associations of the AGTR1 gene with essential hypertension. Furthermore, Gu and colleagues 31 identified several genetic variants in the AGTR1 gene that predicted BP salt sensitivity. In the current study, we found a significant association between the AGTR1 marker rs16860760 and SBP responses to potassium. Compared with those who were homozygous for the major C allele, T allele carriers showed reduced BP responses to potassium, whereas homozygotes showed no significant BP responses to potassium intake. Similar trends were identified for DBP and MAP responses. Interestingly, the same AGTR1 rs16860760 variant identified in the current study was recently reported to be associated with diastolic heart failure, an important BP-related condition, among a Taiwanese population of Han Chinese ethnicity. 32 It is unlikely that this intronic variant is causally associated with either trait. Because this SNP was not in strong linkage disequilibrium (r 2 Ͼ0.8) with any of the other SNPs genotyped in the current study, further studies to identify the true causal variant are warranted. In addition, although some of the linkage findings on chromosome 3 were explained by this SNP, a significant signal was still observed for percent DBP response to potassium after adjustment for rs1680760. These data suggest that other important and still unidentified genes for potassium sensitivity may exist in this region.
Our strongest evidence of linkage to potassium sensitivity was at chromosomal region 11q22.3-q24.3 (LOD score, 4.48). Previous studies have linked this region to other BP-related phenotypes. 33, 34 For example, a genome scan metaanalysis for hypertension found the strongest evidence of linkage at 11q22.3-q24.1. 33 Similarly, our bivariate linkage analyses suggest that loci in this region may have pleiotropic effects on potassium sensitivity and baseline BP phenotypes. Although follow-up genotyping of positional candidate genes did not reveal any significant findings, this region spans over 20 000 kb and may harbor important, but still undiscovered susceptibility loci for potassium sensitivity. Future investigations aimed at identifying novel genes for potassium sensitivity in this chromosomal region are warranted.
The current study described genetic regions on chromosomes 3 and 11 that may harbor important susceptibility loci for potassium sensitivity. Furthermore, we identified a genetic variant in the AGTR1 gene significantly associated with BP responses to potassium intake. These findings provide early evidence that genetic mechanisms contribute to potassium sensitivity, a unique but particularly relevant phenotype. Further research aimed at identifying novel genes in the chromosomal regions described here is needed. In addition, replication of the AGTR1 locus identified in the current analysis is warranted along with work to uncover the functional AGTR1 variant.
